Black Diamond Therapeutics to Present at the Bank of America Global Research Health Care Conference 2020

    NEXT STORY
    Orion Corporation: Decisions by the AGM on 6 May 2020
    PREV STORY
    Zai Lab Announces NDA for Omadacycline Granted Priority Review by China’s NMPA
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Tonix Pharmaceuticals Acquires Exclusive License to University of Geneva Technology for Oxytocin-Based Treatments for Treating Insulin Resistance, Diabetes and Obesity, Expanding Proprietary Uses for TNX-1900 (Intranasal Potentiated Oxytocin)

    author_avatar
    NASDAQ Market News

    Apricus Biosciences Announces Sale of Ex-U.S. Vitaros Assets and Rights to Ferring Pharmaceuticals

    Apricus Expects to Receive Approximately $12.7 Million from Ferring Apricus to Focus on Vitaros ...

    author_avatar
    NASDAQ Market News

    Five Prime Therapeutics to Present at the 34th Annual J.P. Morgan Healthcare Conference

    SOUTH SAN FRANCISCO, Calif., Jan. 06, 2016 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. ...

    author_avatar
    NASDAQ Market News